Table 1 Demographic and clinical characteristics of acromegaly patients at the time of diagnosis
|  | SE ± mean (Range) |  | n | (%) |
|---|---|---|---|---|
Age (years) | 46.2 ± 1.4 (18–75) | Number of microadenomas | 8/62 | (13%) |
Age at the time of diagnosis (years) | 38.2 ± 1.4 (8–65) | Number of macroadenomas | 54/62 | (87%) |
Time to diagnosis (years) | 4.5 ± 0.3 (1–14) | Hyperprolactinemia | 13/62 | (21%) |
Follow-up duration | 7.3 ± 0.8 (1–29) | Hypertension | 13/62 | (21%) |
GH level (ng/ml); (n = 54) | 39.18 (2.1–179) | Diabetes Mellitus | 22/62 | (35%) |
#IGF-1 level (ng/ml); (n = 41) | 993.5 ± 79 (262–3000) | Carpal Tunnel Syndrome | 2/62 | (3.2%) |
IGF-1 level (n = 1)* | 1700 ± 0 | Menstrual irregularity | 4/32 | (12.5%) |
IGF-1 levels (n = 4)** | 1318 ± 788 | Loss of libido | 2/62 | (3.2%) |
IGF-1 levels (n = 17)*** | 770.5 ± 694 | Galactorrhea | 4/62 | (6.5%) |
IGF-1 levels (n = 19)**** | 1078 ± 1249 | Headache | 4/62 | (6.5%) |
| Â | Â | Typical facial findings and growth in hands and feet | 55/62 | (92%) |